Jim Sergi is the Founder and the President of CSSi LifeSciences, a global drug discovery and technology development company providing fully integrated, specialized regulatory and clinical services for pharmaceutical and medical device companies. Prior to this role, Jim was the founder and managing partner of Bay Tower Capital, a life sciences merchant bank and the co-founder and CEO of ProED Communications, a healthcare services and drug development company. Jim has been responsible for over 85 successful NDA/BLA approvals and over 250 medical device approvals. His academic and medical experience includes Director of Experimental Therapeutics at the Cleveland Clinic Cancer Center, Associate Professor of Medical-Surgical Nursing at the Case Western Reserve University. Lecturer for Oncology at Cleveland State University and Adjunct Faculty and Lecturer for biotechnology at Georgetown University and John Hopkins University Graduate Schools. He has authored over 50 peer reviewed publications and has numerous issued patents. Jim serves a scientific reviewer for the NIH SBIR/STTR Commercial Readiness Program, as well as a mentor to the NIH/NHLBI and the NIH Larta FeedForward programs. Jim also serves as a scientific advisor and board member to numerous nonprofits, corporations, private equity and venture backed investment firms, including Defta Partners. Jim has an undergraduate degree in nursing from Edinboro University of Pennsylvania and a graduate degree from the University of Akron. Jim also serves as the GP of Ternary BioVentures, a venture formation life sciences fund to accelerate and de-risk breakthrough drugs and medical devices to transform patient lives. Jim enjoys open water swimming, fly fishing and cooking in his spare time.